<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-04-01" modified="2018-01-31" version="205">
<accession>P07333</accession>
<accession>B5A955</accession>
<accession>D3DQG2</accession>
<accession>Q6LDW5</accession>
<accession>Q6LDY4</accession>
<accession>Q86VW7</accession>
<name>CSF1R_HUMAN</name>
<protein>
<recommendedName>
<fullName>Macrophage colony-stimulating factor 1 receptor</fullName>
</recommendedName>
<alternativeName>
<fullName>CSF-1 receptor</fullName>
<shortName>CSF-1-R</shortName>
<shortName>CSF-1R</shortName>
<shortName>M-CSF-R</shortName>
<ecNumber>2.7.10.1</ecNumber>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Fms</fullName>
</alternativeName>
<cdAntigenName>CD115</cdAntigenName>
</protein>
<gene>
<name type="primary">CSF1R</name>
<name type="synonym">FMS</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Oncogene Res." volume="4" first="9" last="17">
<title>Nucleotide sequence and structural organization of the human FMS proto-oncogene.</title>
<authorList>
<person name="Hampe A."/>
<person name="Shamoon B.M."/>
<person name="Gobet M."/>
<person name="Sherr C.J."/>
<person name="Galibert F."/>
</authorList>
<dbReference type="PubMed" id="2524025"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="Nature" volume="320" first="277" last="280">
<title>Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.</title>
<authorList>
<person name="Coussens L."/>
<person name="van Beveren C."/>
<person name="Smith D."/>
<person name="Chen E."/>
<person name="Mitchell R.L."/>
<person name="Isacke C.M."/>
<person name="Verma I.M."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="2421165"/>
<dbReference type="DOI" id="10.1038/320277a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Genomics" volume="39" first="216" last="226">
<title>Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes.</title>
<authorList>
<person name="Andre C."/>
<person name="Hampe A."/>
<person name="Lachaume P."/>
<person name="Martin E."/>
<person name="Wang X.P."/>
<person name="Manus V."/>
<person name="Hu W.X."/>
<person name="Galibert F."/>
</authorList>
<dbReference type="PubMed" id="9027509"/>
<dbReference type="DOI" id="10.1006/geno.1996.4482"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Arthritis Res. Ther." volume="10" first="R73" last="R73">
<title>Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.</title>
<authorList>
<person name="Jin P."/>
<person name="Zhang J."/>
<person name="Sumariwalla P.F."/>
<person name="Ni I."/>
<person name="Jorgensen B."/>
<person name="Crawford D."/>
<person name="Phillips S."/>
<person name="Feldmann M."/>
<person name="Shepard H.M."/>
<person name="Paleolog E.M."/>
</authorList>
<dbReference type="PubMed" id="18593464"/>
<dbReference type="DOI" id="10.1186/ar2447"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="Mol. Cell. Biol." volume="9" first="1336" last="1341">
<title>Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.</title>
<authorList>
<person name="Visvader J."/>
<person name="Verma I.M."/>
</authorList>
<dbReference type="PubMed" id="2524648"/>
<dbReference type="DOI" id="10.1128/MCB.9.3.1336"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1986" name="J. Virol." volume="59" first="224" last="233">
<title>The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.</title>
<authorList>
<person name="Wheeler E.F."/>
<person name="Roussel M.F."/>
<person name="Hampe A."/>
<person name="Walker M.H."/>
<person name="Fried V.A."/>
<person name="Look A.T."/>
<person name="Rettenmier C.W."/>
<person name="Sherr C.J."/>
</authorList>
<dbReference type="PubMed" id="3525854"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16</scope>
</reference>
<reference key="10">
<citation type="submission" date="1996-11" db="EMBL/GenBank/DDBJ databases">
<title>Expression of a novel exon in the 5' UTR of human c-fms transcripts.</title>
<authorList>
<person name="Flick M.B."/>
<person name="Sapi E."/>
<person name="Kacinski B.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1985" name="Cell" volume="42" first="421" last="428">
<title>Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome.</title>
<authorList>
<person name="Nienhuis A.W."/>
<person name="Bunn H.F."/>
<person name="Turner P.H."/>
<person name="Gopal T.V."/>
<person name="Nash W.G."/>
<person name="O'Brien S.J."/>
<person name="Sherr C.J."/>
</authorList>
<dbReference type="PubMed" id="4028159"/>
<dbReference type="DOI" id="10.1016/0092-8674(85)90099-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 244-295</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="7800" last="7804">
<title>'Replacement' of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.</title>
<authorList>
<person name="Browning P.J."/>
<person name="Bunn H.F."/>
<person name="Cline A."/>
<person name="Shuman M."/>
<person name="Nienhuis A.W."/>
</authorList>
<dbReference type="PubMed" id="3532121"/>
<dbReference type="DOI" id="10.1073/pnas.83.20.7800"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 874-972 (ISOFORM 1)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="Blood" volume="81" first="2511" last="2520">
<title>Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine pluripotent hematopoietic NFS-60 cells induces long-term proliferation in response to CSF-1 without loss of erythroid differentiation potential.</title>
<authorList>
<person name="Bourette R.P."/>
<person name="Mouchiroud G."/>
<person name="Ouazana R."/>
<person name="Morle F."/>
<person name="Godet J."/>
<person name="Blanchet J.P."/>
</authorList>
<dbReference type="PubMed" id="7683918"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1993" name="EMBO J." volume="12" first="943" last="950">
<title>Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor.</title>
<authorList>
<person name="Courtneidge S.A."/>
<person name="Dhand R."/>
<person name="Pilat D."/>
<person name="Twamley G.M."/>
<person name="Waterfield M.D."/>
<person name="Roussel M.F."/>
</authorList>
<dbReference type="PubMed" id="7681396"/>
</citation>
<scope>INTERACTION WITH SRC; FYN AND YES1</scope>
<scope>MUTAGENESIS OF TYR-809</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="529" last="542">
<title>Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids.</title>
<authorList>
<person name="Sapi E."/>
<person name="Flick M.B."/>
<person name="Gilmore-Hebert M."/>
<person name="Rodov S."/>
<person name="Kacinski B.M."/>
</authorList>
<dbReference type="PubMed" id="7845678"/>
</citation>
<scope>INDUCTION BY GLUCOCORTICOIDS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="3076" last="3084">
<title>Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation.</title>
<authorList>
<person name="Morley G.M."/>
<person name="Uden M."/>
<person name="Gullick W.J."/>
<person name="Dibb N.J."/>
</authorList>
<dbReference type="PubMed" id="10340379"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202646"/>
</citation>
<scope>MUTAGENESIS OF TYR-708 AND ASP-802</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38628" last="38636">
<title>The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.</title>
<authorList>
<person name="Baran C.P."/>
<person name="Tridandapani S."/>
<person name="Helgason C.D."/>
<person name="Humphries R.K."/>
<person name="Krystal G."/>
<person name="Marsh C.B."/>
</authorList>
<dbReference type="PubMed" id="12882960"/>
<dbReference type="DOI" id="10.1074/jbc.M305021200"/>
</citation>
<scope>FUNCTION IN CELLULAR SIGNALING; PHOSPHORYLATION OF INPP5D AND ACTIVATION OF AKT1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="165" first="263" last="273">
<title>Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture.</title>
<authorList>
<person name="Wrobel C.N."/>
<person name="Debnath J."/>
<person name="Lin E."/>
<person name="Beausoleil S."/>
<person name="Roussel M.F."/>
<person name="Brugge J.S."/>
</authorList>
<dbReference type="PubMed" id="15117969"/>
<dbReference type="DOI" id="10.1083/jcb.200309102"/>
</citation>
<scope>FUNCTION IN REGULATION OF CELL PROLIFERATION; CELL ADHESION; CELL SHAPE AND INTEGRITY OF CELL JUNCTIONS</scope>
<scope>MUTAGENESIS OF LEU-301 AND TYR-969</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-302 AND ASN-353</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Mol. Cancer Ther." volume="5" first="1007" last="1013">
<title>Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors.</title>
<authorList>
<person name="Guo J."/>
<person name="Marcotte P.A."/>
<person name="McCall J.O."/>
<person name="Dai Y."/>
<person name="Pease L.J."/>
<person name="Michaelides M.R."/>
<person name="Davidsen S.K."/>
<person name="Glaser K.B."/>
</authorList>
<dbReference type="PubMed" id="16648572"/>
<dbReference type="DOI" id="10.1158/1535-7163.MCT-05-0359"/>
</citation>
<scope>FUNCTION AS CSF1 RECEPTOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ROLE IN DISEASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Mol. Cancer Ther." volume="5" first="2634" last="2643">
<title>A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.</title>
<authorList>
<person name="Ohno H."/>
<person name="Kubo K."/>
<person name="Murooka H."/>
<person name="Kobayashi Y."/>
<person name="Nishitoba T."/>
<person name="Shibuya M."/>
<person name="Yoneda T."/>
<person name="Isoe T."/>
</authorList>
<dbReference type="PubMed" id="17121910"/>
<dbReference type="DOI" id="10.1158/1535-7163.MCT-05-0313"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ROLE IN DISEASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="147" last="151">
<title>FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.</title>
<authorList>
<person name="Taylor J.R."/>
<person name="Brownlow N."/>
<person name="Domin J."/>
<person name="Dibb N.J."/>
</authorList>
<dbReference type="PubMed" id="16170366"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209007"/>
</citation>
<scope>FUNCTION IN REGULATION OF CELL PROLIFERATION AND CELL SHAPE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>UBIQUITINATION</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF ASP-802</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Science" volume="320" first="807" last="811">
<title>Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.</title>
<authorList>
<person name="Lin H."/>
<person name="Lee E."/>
<person name="Hestir K."/>
<person name="Leo C."/>
<person name="Huang M."/>
<person name="Bosch E."/>
<person name="Halenbeck R."/>
<person name="Wu G."/>
<person name="Zhou A."/>
<person name="Behrens D."/>
<person name="Hollenbaugh D."/>
<person name="Linnemann T."/>
<person name="Qin M."/>
<person name="Wong J."/>
<person name="Chu K."/>
<person name="Doberstein S.K."/>
<person name="Williams L.T."/>
</authorList>
<dbReference type="PubMed" id="18467591"/>
<dbReference type="DOI" id="10.1126/science.1154370"/>
</citation>
<scope>FUNCTION AS IL34 RECEPTOR</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Int. J. Cancer" volume="124" first="215" last="222">
<title>Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.</title>
<authorList>
<person name="Hiraga T."/>
<person name="Nakamura H."/>
</authorList>
<dbReference type="PubMed" id="18814279"/>
<dbReference type="DOI" id="10.1002/ijc.23903"/>
</citation>
<scope>ROLE IN DISEASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Cancer Res." volume="69" first="9498" last="9506">
<title>Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.</title>
<authorList>
<person name="Patsialou A."/>
<person name="Wyckoff J."/>
<person name="Wang Y."/>
<person name="Goswami S."/>
<person name="Stanley E.R."/>
<person name="Condeelis J.S."/>
</authorList>
<dbReference type="PubMed" id="19934330"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-09-1868"/>
</citation>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-699 AND SER-713</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem." volume="18" first="1789" last="1797">
<title>Colony stimulating factor-1 receptor as a target for small molecule inhibitors.</title>
<authorList>
<person name="Mashkani B."/>
<person name="Griffith R."/>
<person name="Ashman L.K."/>
</authorList>
<dbReference type="PubMed" id="20156689"/>
<dbReference type="DOI" id="10.1016/j.bmc.2010.01.056"/>
</citation>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Cell Death Differ." volume="17" first="1917" last="1927">
<title>IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation.</title>
<authorList>
<person name="Chihara T."/>
<person name="Suzu S."/>
<person name="Hassan R."/>
<person name="Chutiwitoonchai N."/>
<person name="Hiyoshi M."/>
<person name="Motoyoshi K."/>
<person name="Kimura F."/>
<person name="Okada S."/>
</authorList>
<dbReference type="PubMed" id="20489731"/>
<dbReference type="DOI" id="10.1038/cdd.2010.60"/>
</citation>
<scope>FUNCTION AS RECEPTOR FOR IL34 AND CSF1</scope>
<scope>PHOSPHORYLATION AT TYR-546; TYR-699; TYR-708; TYR-723 AND TYR-809</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH IL34 AND CSF1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Cytokine" volume="52" first="215" last="220">
<title>Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood.</title>
<authorList>
<person name="Eda H."/>
<person name="Zhang J."/>
<person name="Keith R.H."/>
<person name="Michener M."/>
<person name="Beidler D.R."/>
<person name="Monahan J.B."/>
</authorList>
<dbReference type="PubMed" id="20829061"/>
<dbReference type="DOI" id="10.1016/j.cyto.2010.08.005"/>
</citation>
<scope>FUNCTION IN RELEASE OF PROINFLAMMATORY CHEMOKINES</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="J. Leukoc. Biol." volume="88" first="495" last="505">
<title>Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.</title>
<authorList>
<person name="Wei S."/>
<person name="Nandi S."/>
<person name="Chitu V."/>
<person name="Yeung Y.G."/>
<person name="Yu W."/>
<person name="Huang M."/>
<person name="Williams L.T."/>
<person name="Lin H."/>
<person name="Stanley E.R."/>
</authorList>
<dbReference type="PubMed" id="20504948"/>
<dbReference type="DOI" id="10.1189/jlb.1209822"/>
</citation>
<scope>FUNCTION AS IL34 AND CSF1 RECEPTOR; ACTIVATION OF MAPK1/ERK2; MAPK3/ERK1; PHOSPHORYLATION AT TYR-723</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Trends Cell Biol." volume="14" first="628" last="638">
<title>CSF-1 regulation of the wandering macrophage: complexity in action.</title>
<authorList>
<person name="Pixley F.J."/>
<person name="Stanley E.R."/>
</authorList>
<dbReference type="PubMed" id="15519852"/>
<dbReference type="DOI" id="10.1016/j.tcb.2004.09.016"/>
</citation>
<scope>REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Curr. Opin. Immunol." volume="18" first="39" last="48">
<title>Colony-stimulating factor-1 in immunity and inflammation.</title>
<authorList>
<person name="Chitu V."/>
<person name="Stanley E.R."/>
</authorList>
<dbReference type="PubMed" id="16337366"/>
<dbReference type="DOI" id="10.1016/j.coi.2005.11.006"/>
</citation>
<scope>REVIEW ON FUNCTION IN IMMUNITY AND INFLAMMATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Int. Immunopharmacol." volume="8" first="1354" last="1376">
<title>Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies.</title>
<authorList>
<person name="Douglass T.G."/>
<person name="Driggers L."/>
<person name="Zhang J.G."/>
<person name="Hoa N."/>
<person name="Delgado C."/>
<person name="Williams C.C."/>
<person name="Dan Q."/>
<person name="Sanchez R."/>
<person name="Jeffes E.W."/>
<person name="Wepsic H.T."/>
<person name="Myers M.P."/>
<person name="Koths K."/>
<person name="Jadus M.R."/>
</authorList>
<dbReference type="PubMed" id="18687298"/>
<dbReference type="DOI" id="10.1016/j.intimp.2008.04.016"/>
</citation>
<scope>REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Annu. Rev. Immunol." volume="27" first="669" last="692">
<title>Blood monocytes: development, heterogeneity, and relationship with dendritic cells.</title>
<authorList>
<person name="Auffray C."/>
<person name="Sieweke M.H."/>
<person name="Geissmann F."/>
</authorList>
<dbReference type="PubMed" id="19132917"/>
<dbReference type="DOI" id="10.1146/annurev.immunol.021908.132557"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="4094" last="4101">
<title>Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors.</title>
<authorList>
<person name="Schubert C."/>
<person name="Schalk-Hihi C."/>
<person name="Struble G.T."/>
<person name="Ma H.C."/>
<person name="Petrounia I.P."/>
<person name="Brandt B."/>
<person name="Deckman I.C."/>
<person name="Patch R.J."/>
<person name="Player M.R."/>
<person name="Spurlino J.C."/>
<person name="Springer B.A."/>
</authorList>
<dbReference type="PubMed" id="17132624"/>
<dbReference type="DOI" id="10.1074/jbc.M608183200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 538-922 IN COMPLEXES WITH ARYLAMIDE AND QUINOLONE INHIBITORS</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="367" first="839" last="847">
<title>The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain.</title>
<authorList>
<person name="Walter M."/>
<person name="Lucet I.S."/>
<person name="Patel O."/>
<person name="Broughton S.E."/>
<person name="Bamert R."/>
<person name="Williams N.K."/>
<person name="Fantino E."/>
<person name="Wilks A.F."/>
<person name="Rossjohn J."/>
</authorList>
<dbReference type="PubMed" id="17292918"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.01.036"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 543-918 IN AUTOINHIBITED CONFORMATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Bioorg. Med. Chem. Lett." volume="18" first="2355" last="2361">
<title>Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors.</title>
<authorList>
<person name="Huang H."/>
<person name="Hutta D.A."/>
<person name="Hu H."/>
<person name="DesJarlais R.L."/>
<person name="Schubert C."/>
<person name="Petrounia I.P."/>
<person name="Chaikin M.A."/>
<person name="Manthey C.L."/>
<person name="Player M.R."/>
</authorList>
<dbReference type="PubMed" id="18342505"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2008.02.070"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 538-922 IN COMPLEX WITH PYRIMIDINOPYRIDONE INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="J. Med. Chem." volume="52" first="1081" last="1099">
<title>Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors.</title>
<authorList>
<person name="Huang H."/>
<person name="Hutta D.A."/>
<person name="Rinker J.M."/>
<person name="Hu H."/>
<person name="Parsons W.H."/>
<person name="Schubert C."/>
<person name="DesJarlais R.L."/>
<person name="Crysler C.S."/>
<person name="Chaikin M.A."/>
<person name="Donatelli R.R."/>
<person name="Chen Y."/>
<person name="Cheng D."/>
<person name="Zhou Z."/>
<person name="Yurkow E."/>
<person name="Manthey C.L."/>
<person name="Player M.R."/>
</authorList>
<dbReference type="PubMed" id="19193011"/>
<dbReference type="DOI" id="10.1021/jm801406h"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 538-922 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION IN INFLAMMATION AND DISEASE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="1543" last="1547">
<title>Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode.</title>
<authorList>
<person name="Meyers M.J."/>
<person name="Pelc M."/>
<person name="Kamtekar S."/>
<person name="Day J."/>
<person name="Poda G.I."/>
<person name="Hall M.K."/>
<person name="Michener M.L."/>
<person name="Reitz B.A."/>
<person name="Mathis K.J."/>
<person name="Pierce B.S."/>
<person name="Parikh M.D."/>
<person name="Mischke D.A."/>
<person name="Long S.A."/>
<person name="Parlow J.J."/>
<person name="Anderson D.R."/>
<person name="Thorarensen A."/>
</authorList>
<dbReference type="PubMed" id="20137931"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.01.078"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 538-922 IN COMPLEXES WITH INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLY-32; ARG-362; SER-413; VAL-536; HIS-693; ASP-920 AND GLN-921</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="200" last="205">
<title>Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.</title>
<authorList>
<person name="Rademakers R."/>
<person name="Baker M."/>
<person name="Nicholson A.M."/>
<person name="Rutherford N.J."/>
<person name="Finch N."/>
<person name="Soto-Ortolaza A."/>
<person name="Lash J."/>
<person name="Wider C."/>
<person name="Wojtas A."/>
<person name="DeJesus-Hernandez M."/>
<person name="Adamson J."/>
<person name="Kouri N."/>
<person name="Sundal C."/>
<person name="Shuster E.A."/>
<person name="Aasly J."/>
<person name="MacKenzie J."/>
<person name="Roeber S."/>
<person name="Kretzschmar H.A."/>
<person name="Boeve B.F."/>
<person name="Knopman D.S."/>
<person name="Petersen R.C."/>
<person name="Cairns N.J."/>
<person name="Ghetti B."/>
<person name="Spina S."/>
<person name="Garbern J."/>
<person name="Tselis A.C."/>
<person name="Uitti R."/>
<person name="Das P."/>
<person name="Van Gerpen J.A."/>
<person name="Meschia J.F."/>
<person name="Levy S."/>
<person name="Broderick D.F."/>
<person name="Graff-Radford N."/>
<person name="Ross O.A."/>
<person name="Miller B.B."/>
<person name="Swerdlow R.H."/>
<person name="Dickson D.W."/>
<person name="Wszolek Z.K."/>
</authorList>
<dbReference type="PubMed" id="22197934"/>
<dbReference type="DOI" id="10.1038/ng.1027"/>
</citation>
<scope>VARIANTS HDLS 774-CYS--ASN-814 DEL; 585-GLY--LYS-619 DELINS ALA; GLU-589; LYS-633; THR-766; PRO-770; ASN-775; THR-794; TYR-837; SER-849; PHE-849 DEL; PRO-868; THR-875 AND THR-878</scope>
<scope>VARIANTS HIS-710; ARG-747 AND ASP-920</scope>
<scope>CHARACTERIZATION OF VARIANTS HDLS LYS-633; THR-766 AND THR-875</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="J. Neurol." volume="261" first="768" last="772">
<title>Hereditary diffuse leukoencephalopathy with axonal spheroids: three patients with stroke-like presentation carrying new mutations in the CSF1R gene.</title>
<authorList>
<person name="Battisti C."/>
<person name="Di Donato I."/>
<person name="Bianchi S."/>
<person name="Monti L."/>
<person name="Formichi P."/>
<person name="Rufa A."/>
<person name="Taglia I."/>
<person name="Cerase A."/>
<person name="Dotti M.T."/>
<person name="Federico A."/>
</authorList>
<dbReference type="PubMed" id="24532199"/>
<dbReference type="DOI" id="10.1007/s00415-014-7257-3"/>
</citation>
<scope>VARIANTS HDLS ARG-653; PHE-843 AND THR-906</scope>
</reference>
<comment type="function">
<text evidence="17 18 19 21 22 23 26 27 28 29 32 33 34 38">Tyrosine-protein kinase that acts as cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of proinflammatory chemokines in response to IL34 and CSF1, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone and tooth development. Required for normal male and female fertility, and for normal development of milk ducts and acinar structures in the mammary gland during pregnancy. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration, and promotes cancer cell invasion. Activates several signaling pathways in response to ligand binding. Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, that then lead to the activation of protein kinase C family members, especially PRKCD. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to activation of the AKT1 signaling pathway. Activated CSF1R also mediates activation of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family kinases SRC, FYN and YES1. Activated CSF1R transmits signals both via proteins that directly interact with phosphorylated tyrosine residues in its intracellular domain, or via adapter proteins, such as GRB2. Promotes activation of STAT family members STAT3, STAT5A and/or STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP-1. Receptor signaling is down-regulated by protein phosphatases, such as INPP5D/SHIP-1, that dephosphorylate the receptor and its downstream effectors, and by rapid internalization of the activated receptor.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15 19 22 23 25 28 30">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="19 22 23 27 30 31 32">Present in an inactive conformation in the absence of bound ligand. CSF1 or IL34 binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by imatinib/STI-571 (Gleevec), dasatinib, sunitinib/SU11248, lestaurtinib/CEP-701, midostaurin/PKC-412, Ki20227, linifanib/ABT-869, Axitinib/AG013736, sorafenib/BAY 43-9006 and GW2580.</text>
</comment>
<comment type="subunit">
<text evidence="10 25 28 32 37">Interacts with INPPL1/SHIP2 and THOC5 (By similarity). Monomer. Homodimer. Interacts with CSF1 and IL34. Interaction with dimeric CSF1 or IL34 leads to receptor homodimerization. Interacts (tyrosine phosphorylated) with PLCG2 (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1 (via SH2 domain). Interacts (tyrosine phosphorylated) with FYN, YES1 and SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with CBL, GRB2 and SLA2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2835440"/>
<interactant intactId="EBI-2872294">
<id>P09603</id>
<label>CSF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2835440"/>
<interactant intactId="EBI-15978980">
<id>Q6ZMJ4-1</id>
<label>IL34</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P07333-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P07333-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047757 VSP_047758"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Expressed in bone marrow and in differentiated blood mononuclear cells.</text>
</comment>
<comment type="induction">
<text evidence="39">Up-regulated by glucocorticoids.</text>
</comment>
<comment type="domain">
<text>The juxtamembrane domain functions as autoinhibitory region. Phosphorylation of tyrosine residues in this region leads to a conformation change and activation of the kinase.</text>
</comment>
<comment type="domain">
<text>The activation loop plays an important role in the regulation of kinase activity. Phosphorylation of tyrosine residues in this region leads to a conformation change and activation of the kinase.</text>
</comment>
<comment type="PTM">
<text evidence="19 32">Autophosphorylated in response to CSF1 or IL34 binding. Phosphorylation at Tyr-561 is important for normal down-regulation of signaling by ubiquitination, internalization and degradation. Phosphorylation at Tyr-561 and Tyr-809 is important for interaction with SRC family members, including FYN, YES1 and SRC, and for subsequent activation of these protein kinases. Phosphorylation at Tyr-699 and Tyr-923 is important for interaction with GRB2. Phosphorylation at Tyr-723 is important for interaction with PIK3R1. Phosphorylation at Tyr-708 is important for normal receptor degradation. Phosphorylation at Tyr-723 and Tyr-809 is important for interaction with PLCG2. Phosphorylation at Tyr-969 is important for interaction with CBL. Dephosphorylation by PTPN2 negatively regulates downstream signaling and macrophage differentiation.</text>
</comment>
<comment type="PTM">
<text evidence="19">Ubiquitinated. Becomes rapidly polyubiquitinated after autophosphorylation, leading to its degradation.</text>
</comment>
<comment type="disease">
<text>Aberrant expression of CSF1 or CSF1R can promote cancer cell proliferation, invasion and formation of metastases. Overexpression of CSF1 or CSF1R is observed in a significant percentage of breast, ovarian, prostate, and endometrial cancers.</text>
</comment>
<comment type="disease">
<text>Aberrant expression of CSF1 or CSF1R may play a role in inflammatory diseases, such as rheumatoid arthritis, glomerulonephritis, atherosclerosis, and allograft rejection.</text>
</comment>
<comment type="disease" evidence="35 36">
<disease id="DI-03392">
<name>Leukoencephalopathy, diffuse hereditary, with spheroids</name>
<acronym>HDLS</acronym>
<description>An autosomal dominant adult-onset rapidly progressive neurodegenerative disorder characterized by variable behavioral, cognitive, and motor changes. Patients often die of dementia within 6 years of onset. Brain imaging shows patchy abnormalities in the cerebral white matter, predominantly affecting the frontal and parietal lobes.</description>
<dbReference type="MIM" id="221820"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="14">Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CSF1RID40161ch5q32.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="X03663">
<property type="protein sequence ID" value="CAA27300.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U63963">
<property type="protein sequence ID" value="AAB51696.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M25786">
<property type="protein sequence ID" value="AAA58421.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU826593">
<property type="protein sequence ID" value="ACF47629.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011382">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61749.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61750.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC047521">
<property type="protein sequence ID" value="AAH47521.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M14002">
<property type="protein sequence ID" value="AAA35849.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78096">
<property type="protein sequence ID" value="AAB51235.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M11067">
<property type="protein sequence ID" value="AAA35848.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M14193">
<property type="protein sequence ID" value="AAA35834.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4302.1">
<molecule id="P07333-1"/>
</dbReference>
<dbReference type="PIR" id="S08123">
<property type="entry name" value="TVHUMD"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001275634.1">
<molecule id="P07333-1"/>
<property type="nucleotide sequence ID" value="NM_001288705.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005202.2">
<molecule id="P07333-1"/>
<property type="nucleotide sequence ID" value="NM_005211.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.586219"/>
<dbReference type="PDB" id="2I0V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=538-678, A=753-922"/>
</dbReference>
<dbReference type="PDB" id="2I0Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=538-678, A=753-922"/>
</dbReference>
<dbReference type="PDB" id="2I1M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=538-678, A=753-922"/>
</dbReference>
<dbReference type="PDB" id="2OGV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=543-918"/>
</dbReference>
<dbReference type="PDB" id="3BEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=538-678, A=753-922"/>
</dbReference>
<dbReference type="PDB" id="3DPK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=538-678, A=771-922"/>
</dbReference>
<dbReference type="PDB" id="3KRJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=538-678, A=753-922"/>
</dbReference>
<dbReference type="PDB" id="3KRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=538-678, A=753-922"/>
</dbReference>
<dbReference type="PDB" id="3LCD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=538-919"/>
</dbReference>
<dbReference type="PDB" id="3LCO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=550-919"/>
</dbReference>
<dbReference type="PDB" id="4DKD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C=20-299"/>
</dbReference>
<dbReference type="PDB" id="4HW7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=542-919"/>
</dbReference>
<dbReference type="PDB" id="4LIQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="E=2-512"/>
</dbReference>
<dbReference type="PDB" id="4R7H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=542-919"/>
</dbReference>
<dbReference type="PDB" id="4R7I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=542-919"/>
</dbReference>
<dbReference type="PDB" id="4WRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/C=20-296"/>
</dbReference>
<dbReference type="PDB" id="4WRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="6.85"/>
<property type="chains" value="A=20-504"/>
</dbReference>
<dbReference type="PDBsum" id="2I0V"/>
<dbReference type="PDBsum" id="2I0Y"/>
<dbReference type="PDBsum" id="2I1M"/>
<dbReference type="PDBsum" id="2OGV"/>
<dbReference type="PDBsum" id="3BEA"/>
<dbReference type="PDBsum" id="3DPK"/>
<dbReference type="PDBsum" id="3KRJ"/>
<dbReference type="PDBsum" id="3KRL"/>
<dbReference type="PDBsum" id="3LCD"/>
<dbReference type="PDBsum" id="3LCO"/>
<dbReference type="PDBsum" id="4DKD"/>
<dbReference type="PDBsum" id="4HW7"/>
<dbReference type="PDBsum" id="4LIQ"/>
<dbReference type="PDBsum" id="4R7H"/>
<dbReference type="PDBsum" id="4R7I"/>
<dbReference type="PDBsum" id="4WRL"/>
<dbReference type="PDBsum" id="4WRM"/>
<dbReference type="ProteinModelPortal" id="P07333"/>
<dbReference type="SMR" id="P07333"/>
<dbReference type="BioGrid" id="107823">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="DIP" id="DIP-59421N"/>
<dbReference type="IntAct" id="P07333">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="MINT-8019993"/>
<dbReference type="STRING" id="9606.ENSP00000286301"/>
<dbReference type="BindingDB" id="P07333"/>
<dbReference type="ChEMBL" id="CHEMBL1844"/>
<dbReference type="DrugBank" id="DB07167">
<property type="generic name" value="5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07202">
<property type="generic name" value="6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB06080">
<property type="generic name" value="ABT-869"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01268">
<property type="generic name" value="Sunitinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1806"/>
<dbReference type="iPTMnet" id="P07333"/>
<dbReference type="PhosphoSitePlus" id="P07333"/>
<dbReference type="BioMuta" id="CSF1R"/>
<dbReference type="DMDM" id="547770"/>
<dbReference type="EPD" id="P07333"/>
<dbReference type="PaxDb" id="P07333"/>
<dbReference type="PeptideAtlas" id="P07333"/>
<dbReference type="PRIDE" id="P07333"/>
<dbReference type="DNASU" id="1436"/>
<dbReference type="Ensembl" id="ENST00000286301">
<molecule id="P07333-1"/>
<property type="protein sequence ID" value="ENSP00000286301"/>
<property type="gene ID" value="ENSG00000182578"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000543093">
<molecule id="P07333-2"/>
<property type="protein sequence ID" value="ENSP00000445282"/>
<property type="gene ID" value="ENSG00000182578"/>
</dbReference>
<dbReference type="GeneID" id="1436"/>
<dbReference type="KEGG" id="hsa:1436"/>
<dbReference type="UCSC" id="uc003lrm.3">
<molecule id="P07333-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1436"/>
<dbReference type="DisGeNET" id="1436"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000182578.13"/>
<dbReference type="GeneCards" id="CSF1R"/>
<dbReference type="GeneReviews" id="CSF1R"/>
<dbReference type="HGNC" id="HGNC:2433">
<property type="gene designation" value="CSF1R"/>
</dbReference>
<dbReference type="HPA" id="CAB008970"/>
<dbReference type="HPA" id="HPA012323"/>
<dbReference type="MalaCards" id="CSF1R"/>
<dbReference type="MIM" id="164770">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="221820">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P07333"/>
<dbReference type="OpenTargets" id="ENSG00000182578"/>
<dbReference type="Orphanet" id="313808">
<property type="disease" value="Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26936"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000112008"/>
<dbReference type="HOVERGEN" id="HBG004335"/>
<dbReference type="InParanoid" id="P07333"/>
<dbReference type="KO" id="K05090"/>
<dbReference type="OMA" id="WKIIESY"/>
<dbReference type="OrthoDB" id="EOG091G01TL"/>
<dbReference type="PhylomeDB" id="P07333"/>
<dbReference type="TreeFam" id="TF325768"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-449836">
<property type="pathway name" value="Other interleukin signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P07333"/>
<dbReference type="SIGNOR" id="P07333"/>
<dbReference type="ChiTaRS" id="CSF1R">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P07333"/>
<dbReference type="GeneWiki" id="Colony_stimulating_factor_1_receptor"/>
<dbReference type="GenomeRNAi" id="1436"/>
<dbReference type="PRO" id="PR:P07333"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000182578"/>
<dbReference type="CleanEx" id="HS_CSF1R"/>
<dbReference type="ExpressionAtlas" id="P07333">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P07333">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990682">
<property type="term" value="C:CSF1-CSF1R complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019955">
<property type="term" value="F:cytokine binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005011">
<property type="term" value="F:macrophage colony-stimulating factor receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045217">
<property type="term" value="P:cell-cell junction maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036006">
<property type="term" value="P:cellular response to macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021879">
<property type="term" value="P:forebrain neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0038145">
<property type="term" value="P:macrophage colony-stimulating factor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030225">
<property type="term" value="P:macrophage differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060603">
<property type="term" value="P:mammary gland duct morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030224">
<property type="term" value="P:monocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021772">
<property type="term" value="P:olfactory bulb development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030316">
<property type="term" value="P:osteoclast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046488">
<property type="term" value="P:phosphatidylinositol metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000147">
<property type="term" value="P:positive regulation of cell motility"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090197">
<property type="term" value="P:positive regulation of chemokine secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061098">
<property type="term" value="P:positive regulation of protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000249">
<property type="term" value="P:regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045124">
<property type="term" value="P:regulation of bone resorption"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031529">
<property type="term" value="P:ruffle organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="5"/>
</dbReference>
<dbReference type="InterPro" id="IPR030658">
<property type="entry name" value="CSF-1_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001824">
<property type="entry name" value="Tyr_kinase_rcpt_3_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF500947">
<property type="entry name" value="CSF-1_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00240">
<property type="entry name" value="RECEPTOR_TYR_KIN_III"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="12">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Macrophage colony-stimulating factor 1 receptor" id="PRO_0000016765">
<location>
<begin position="20"/>
<end position="972"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="20"/>
<end position="517"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="12">
<location>
<begin position="518"/>
<end position="538"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="539"/>
<end position="972"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="21"/>
<end position="104"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="107"/>
<end position="197"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="203"/>
<end position="290"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="299"/>
<end position="399"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="402"/>
<end position="502"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="14">
<location>
<begin position="582"/>
<end position="910"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="14">
<location>
<begin position="588"/>
<end position="596"/>
</location>
</feature>
<feature type="region of interest" description="Regulatory juxtamembrane domain">
<location>
<begin position="542"/>
<end position="574"/>
</location>
</feature>
<feature type="region of interest" description="Activation loop">
<location>
<begin position="796"/>
<end position="818"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14 15">
<location>
<position position="778"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="41">
<location>
<position position="616"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="32">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="11">
<location>
<position position="561"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="9 32">
<location>
<position position="699"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="32">
<location>
<position position="708"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="713"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="32">
<location>
<position position="723"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="32">
<location>
<position position="809"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10">
<location>
<position position="923"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="11">
<location>
<position position="969"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="45"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="73"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="153"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="240"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="275"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20">
<location>
<position position="302"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="335"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20">
<location>
<position position="353"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="412"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="428"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="480"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="42"/>
<end position="84"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="127"/>
<end position="177"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="224"/>
<end position="278"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="419"/>
<end position="485"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047757" evidence="40">
<original>ESAYLNLSSE</original>
<variation>GTPSPSLCPA</variation>
<location>
<begin position="297"/>
<end position="306"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047758" evidence="40">
<location>
<begin position="307"/>
<end position="972"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56048668." id="VAR_042038" evidence="24">
<original>V</original>
<variation>G</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41338945." id="VAR_061290">
<original>A</original>
<variation>S</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3829986." id="VAR_049718">
<original>V</original>
<variation>M</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10079250." id="VAR_042039" evidence="24">
<original>H</original>
<variation>R</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34951517." id="VAR_042040" evidence="24">
<original>G</original>
<variation>S</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55942044." id="VAR_042041" evidence="24">
<original>L</original>
<variation>V</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS." id="VAR_067396" evidence="35">
<original>GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK</original>
<variation>A</variation>
<location>
<begin position="585"/>
<end position="619"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860268." id="VAR_067397" evidence="35">
<original>G</original>
<variation>E</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860269." id="VAR_067398" evidence="35">
<original>E</original>
<variation>K</variation>
<location>
<position position="633"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs690016559." id="VAR_072081" evidence="36">
<original>C</original>
<variation>R</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung squamous cell carcinoma sample; somatic mutation." id="VAR_042042" evidence="24">
<original>P</original>
<variation>H</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201569135." id="VAR_067399" evidence="35">
<original>R</original>
<variation>H</variation>
<location>
<position position="710"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41355444." id="VAR_067400" evidence="35">
<original>G</original>
<variation>R</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860270." id="VAR_067401" evidence="35">
<original>M</original>
<variation>T</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860271." id="VAR_067402" evidence="35">
<original>A</original>
<variation>P</variation>
<location>
<position position="770"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS." id="VAR_067403" evidence="35">
<location>
<begin position="774"/>
<end position="814"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860273." id="VAR_067404" evidence="35">
<original>I</original>
<variation>N</variation>
<location>
<position position="775"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860274." id="VAR_067405" evidence="35">
<original>I</original>
<variation>T</variation>
<location>
<position position="794"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs387906662." id="VAR_067406" evidence="35">
<original>D</original>
<variation>Y</variation>
<location>
<position position="837"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs690016558." id="VAR_072082" evidence="36">
<original>I</original>
<variation>F</variation>
<location>
<position position="843"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860277." id="VAR_067407" evidence="35">
<original>F</original>
<variation>S</variation>
<location>
<position position="849"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS." id="VAR_067408" evidence="35">
<location>
<position position="849"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860278." id="VAR_067409" evidence="35">
<original>L</original>
<variation>P</variation>
<location>
<position position="868"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860279." id="VAR_067410" evidence="35">
<original>M</original>
<variation>T</variation>
<location>
<position position="875"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs281860280." id="VAR_067411" evidence="35">
<original>P</original>
<variation>T</variation>
<location>
<position position="878"/>
</location>
</feature>
<feature type="sequence variant" description="In HDLS; dbSNP:rs690016560." id="VAR_072083" evidence="36">
<original>I</original>
<variation>T</variation>
<location>
<position position="906"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34030164." id="VAR_042043" evidence="24 35">
<original>E</original>
<variation>D</variation>
<location>
<position position="920"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56059682." id="VAR_042044" evidence="24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="921"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801271." id="VAR_011953">
<original>Y</original>
<variation>C</variation>
<location>
<position position="969"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive kinase activity." evidence="18">
<original>L</original>
<variation>S</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs degradation of activated CSF1R." evidence="16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive kinase activity. Loss of inhibition by imatinib." evidence="16 19">
<original>D</original>
<variation>V</variation>
<location>
<position position="802"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced kinase activity. Reduced interaction with SRC, FYN and YES1." evidence="37">
<original>Y</original>
<variation>F</variation>
<location>
<position position="809"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes down-regulation of activated CSF1R." evidence="18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="969"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA27300." ref="2" evidence="41">
<original>P</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH47521." ref="7" evidence="41">
<original>P</original>
<variation>H</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH47521." ref="7" evidence="41">
<original>A</original>
<variation>V</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH47521." ref="7" evidence="41">
<original>A</original>
<variation>S</variation>
<location>
<position position="629"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="22"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="27"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="38"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="49"/>
<end position="51"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="58"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="64"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="76"/>
<end position="78"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="80"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="95"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="108"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="113"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="127"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="132"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="139"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="154"/>
<end position="157"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="158"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="161"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="169"/>
<end position="171"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="173"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="184"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="191"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="204"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="210"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="216"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="220"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="234"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="248"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="257"/>
<end position="267"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="270"/>
<end position="272"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="274"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="285"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="300"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="309"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="319"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="332"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="351"/>
<end position="354"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="361"/>
<end position="368"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="373"/>
<end position="375"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="377"/>
<end position="385"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="388"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="414"/>
<end position="425"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="428"/>
<end position="437"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="443"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="446"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="456"/>
<end position="459"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="466"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="479"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="493"/>
<end position="498"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="551"/>
<end position="553"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="556"/>
<end position="559"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="566"/>
<end position="568"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="573"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="581"/>
<end position="590"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="592"/>
<end position="601"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="605"/>
<end position="607"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="612"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="624"/>
<end position="640"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="649"/>
<end position="653"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="655"/>
<end position="658"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="660"/>
<end position="664"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="671"/>
<end position="682"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="684"/>
<end position="686"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="753"/>
<end position="771"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="781"/>
<end position="783"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="785"/>
<end position="787"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="788"/>
<end position="790"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="791"/>
<end position="794"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="798"/>
<end position="800"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="803"/>
<end position="805"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="806"/>
<end position="808"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="809"/>
<end position="811"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="815"/>
<end position="817"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="819"/>
<end position="821"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="824"/>
<end position="829"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="834"/>
<end position="848"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="849"/>
<end position="851"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="863"/>
<end position="871"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="883"/>
<end position="892"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="897"/>
<end position="899"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="903"/>
<end position="920"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2I1M"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KRJ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LCO"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DKD"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4LIQ"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4R7H"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4R7I"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WRL"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P09581"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10340379"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12882960"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15117969"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16170366"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16337366"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16648572"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17121910"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18342505"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18467591"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18814279"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19193011"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19934330"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20137931"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20156689"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20489731"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20504948"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20829061"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22197934"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24532199"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7681396"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7683918"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7845678"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<sequence length="972" mass="107984" checksum="A8D99BE237573FE8" modified="1994-06-01" version="2" precursor="true">
MGPGVLLLLLVATAWHGQGIPVIEPSVPELVVKPGATVTLRCVGNGSVEWDGPPSPHWTL
YSDGSSSILSTNNATFQNTGTYRCTEPGDPLGGSAAIHLYVKDPARPWNVLAQEVVVFED
QDALLPCLLTDPVLEAGVSLVRVRGRPLMRHTNYSFSPWHGFTIHRAKFIQSQDYQCSAL
MGGRKVMSISIRLKVQKVIPGPPALTLVPAELVRIRGEAAQIVCSASSVDVNFDVFLQHN
NTKLAIPQQSDFHNNRYQKVLTLNLDQVDFQHAGNYSCVASNVQGKHSTSMFFRVVESAY
LNLSSEQNLIQEVTVGEGLNLKVMVEAYPGLQGFNWTYLGPFSDHQPEPKLANATTKDTY
RHTFTLSLPRLKPSEAGRYSFLARNPGGWRALTFELTLRYPPEVSVIWTFINGSGTLLCA
ASGYPQPNVTWLQCSGHTDRCDEAQVLQVWDDPYPEVLSQEPFHKVTVQSLLTVETLEHN
QTYECRAHNSVGSGSWAFIPISAGAHTHPPDEFLFTPVVVACMSIMALLLLLLLLLLYKY
KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT
AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL
VITEYCCYGDLLNFLRRKAEAMLGPSLSPGQDPEGGVDYKNIHLEKKYVRRDSGFSSQGV
DTYVEMRPVSTSSNDSFSEQDLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVA
ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS
YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHR
PTFQQICSFLQEQAQEDRRERDYTNLPSSSRSGGSGSSSSELEEESSSEHLTCCEQGDIA
QPLLQPNNYQFC
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>